Literature DB >> 20816133

Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Suraj Achar1, Armand Rostamian, Sanjiv M Narayan.   

Abstract

Recent surveys and reports suggest that many athletes and bodybuilders abuse anabolic-androgenic steroids (AAS). However, scientific data on the cardiac and metabolic complications of AAS abuse are divergent and often conflicting. A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. Although studies were typically small and retrospective, some associated AAS abuse with unfavorable effects. Otherwise healthy young athletes abusing AAS may show elevated levels of low-density lipoprotein and low levels of high-density lipoprotein. Although data are conflicting, AAS have also been linked with elevated systolic and diastolic blood pressure and with left ventricular hypertrophy that may persist after AAS cessation. Finally, in small case studies, AAS abuse has been linked with acute myocardial infarction and fatal ventricular arrhythmias. In conclusion, recognition of these adverse effects may improve the education of athletes and increase vigilance when evaluating young athletes with cardiovascular abnormalities. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816133      PMCID: PMC4111565          DOI: 10.1016/j.amjcard.2010.05.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  94 in total

1.  Effects of anabolic-androgenic steroids on weight-lifters' myocardium: an ultrasonic videodensitometric study.

Authors:  V Di Bello; D Giorgi; M Bianchi; A Bertini; M T Caputo; G Valenti; O Furioso; L Alessandri; M Paterni; C Giusti
Journal:  Med Sci Sports Exerc       Date:  1999-04       Impact factor: 5.411

2.  Cardiac arrest following anaesthetic induction in a world-class bodybuilder.

Authors:  Allison Angelilli; Edward S Katz; Ronald M Goldenberg
Journal:  Acta Cardiol       Date:  2005-08       Impact factor: 1.718

3.  Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.

Authors:  H A Lane; F Grace; J C Smith; K Morris; J Cockcroft; M F Scanlon; J S Davies
Journal:  Eur J Clin Invest       Date:  2006-07       Impact factor: 4.686

Review 4.  Secondary dyslipidemia. Inadvertent effects of drugs in clinical practice.

Authors:  Y Henkin; J A Como; A Oberman
Journal:  JAMA       Date:  1992-02-19       Impact factor: 56.272

Review 5.  Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders.

Authors:  Vittorio Fineschi; Irene Riezzo; Fabio Centini; Enrico Silingardi; Manuela Licata; Giovanni Beduschi; Steven B Karch
Journal:  Int J Legal Med       Date:  2005-11-15       Impact factor: 2.686

6.  Contrasting effects of testosterone and stanozolol on serum lipoprotein levels.

Authors:  P D Thompson; E M Cullinane; S P Sady; C Chenevert; A L Saritelli; M A Sady; P N Herbert
Journal:  JAMA       Date:  1989-02-24       Impact factor: 56.272

7.  Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

Authors:  A Urhausen; T Albers; W Kindermann
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

8.  Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids.

Authors:  R D Dickerman; F Schaller; I Prather; W J McConathy
Journal:  Cardiology       Date:  1995       Impact factor: 1.869

9.  Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function.

Authors:  B De Piccoli; F Giada; A Benettin; F Sartori; E Piccolo
Journal:  Int J Sports Med       Date:  1991-08       Impact factor: 3.118

Review 10.  Atherogenic effects of anabolic steroids on serum lipid levels. A literature review.

Authors:  G Glazer
Journal:  Arch Intern Med       Date:  1991-10
View more
  54 in total

Review 1.  Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.

Authors:  Eberhard Nieschlag; Elena Vorona
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 2.  New Concepts in Sudden Cardiac Arrest to Address an Intractable Epidemic: JACC State-of-the-Art Review.

Authors:  Sanjiv M Narayan; Paul J Wang; James P Daubert
Journal:  J Am Coll Cardiol       Date:  2019-01-08       Impact factor: 24.094

Review 3.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 4.  [Sports cardiology : Overview of relevant clinical topics].

Authors:  R Laszlo; J Scharhag; C Burgstahler; H Striegel; J M Steinacker
Journal:  Herz       Date:  2017-01-23       Impact factor: 1.443

Review 5.  The role of 20-HETE in androgen-mediated hypertension.

Authors:  Cheng-Chia Wu; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-22       Impact factor: 3.072

Review 6.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

7.  The Effect of Chronic Anabolic-Androgenic Steroid Use on Tp-E Interval, Tp-E/Qt Ratio, and Tp-E/Qtc Ratio in Male Bodybuilders.

Authors:  Elnur Alizade; Anıl Avcı; Serdar Fidan; Mustafa Tabakçı; Mustafa Bulut; Regayip Zehir; Zeki Simsek; Mert Evlice; Uğur Arslantaş; Hakan Çakır; Mehmet Yunus Emiroglu; Mustafa Akçakoyun
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-01-28       Impact factor: 1.468

8.  Testosterone regulates bone response to inflammation.

Authors:  J P Steffens; B S Herrera; L S Coimbra; D N Stephens; C Rossa; L C Spolidorio; A Kantarci; T E Van Dyke
Journal:  Horm Metab Res       Date:  2014-02-13       Impact factor: 2.936

9.  Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns.

Authors:  Barbara Pergolizzi; Vitina Carriero; Giuliana Abbadessa; Claudia Penna; Paola Berchialla; Silvia De Francia; Enrico Bracco; Silvia Racca
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

10.  Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient.

Authors:  Reham Mohammed Shamloul; Ahmed Fathy Aborayah; Assem Hashad; Foad Abd-Allah
Journal:  BMJ Case Rep       Date:  2014-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.